Please login to the form below

Not currently logged in
Email:
Password:

biliary tract cancer

This page shows the latest biliary tract cancer news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca to acquire Neogene Therapeutics in $320m deal

AstraZeneca to acquire Neogene Therapeutics in $320m deal

The agreement will build the company’s pipeline of cell-based cancer treatments. ... of biliary tract cancer, advanced gastric cancer and prostate cancer, respectively.

Latest news

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    This treatment quickly became the ‘gold standard’ for women with metastatic breast cancer. ... biliary tract cancer as well as other solid tumours.

  • Pharma deals continue to slide Pharma deals continue to slide

    Mundipharma built its oncology franchise following the acquisition of an old anti-cancer drug and the deal to license a phase 3 product for biliary tract cancer will provide a new ... CAP7.1 prodrug of etoposide at start phase 3 for second line treatment

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...